- identification and quantification of the key factors affecting mortality/longevity such as lifestyle choices, medical conditions, and/or interventions
- modelling of temporal changes in the factors affecting morbidity and mortality
- evaluation of plausible scenarios in mortality trends due to particular medical advances or lifestyle changes in the population of insureds of relevance to the actuarial community
- tools to forecast longevity risk of a book based on realistic scenarios of uptake of various health behaviours and/or interventions, or of particular disruptions to population health.
Life expectancy calculator
- Science Direct On the survival of individuals diagnosed with type 2 diabetes mellitus in the United Kingdom: A retrospective matched cohort study, April 2022
- BJOG: An International Journal of Obstetrics and Gynaecology The effect of hormone replacement therapy on the survival of UK women: a retrospective cohort study 1984−2017. Nov 2021
- Family Medicine and Community Health Journal Do statins reduce mortality in older people? Findings from longitudinal study using primary care records, May 2021. Blog June 2021
- Insurance Mathematics and Economics Calculation of changes in individual and period life expectancy based on proportional hazards model of an intervention, Nov 2020
- The Actuary A Fine Scale, May 2020
- Journal of Hypertension Optimal systolic blood pressure targets in routine clinical care, Apr 2019
- The Actuary Statins: figures on the pulse, Aug 2018
- BMJ Survival prospects after acute myocardial infarction in the United Kingdom: a matched cohort study 1987-2011, Jan 2017
- Longevity Bulletin Use of big health and actuarial data for understanding longevity and morbidity risk, Dec 2016
- PLOS ONE Survival benefits of statins for primary prevention: a cohort study, Nov 2016
- ARC Webinar Series 2021 - Use of Primary Health Care Records Data in Actuarial Research, 9 March 2021
The research team discussed their findings on the longevity of people with major long-term medical conditions such as diabetes, transient ischaemic attack and stroke and assessed the effects of key treatments such as hormone replacement therapy. A demonstration was given of the mylongevity.org and a shiny app for life expectancy with diabetes.
- ARC Technical Workshop Beyond Proportional Hazards, Staple Inn Hall, Oct 2019
- ARC Sessional How Medical Advances and Health Interventions Will Shape Future Longevity, Mar 2019
- ARC Webinar Series 2018 Use of Big Health and Actuarial Data for understanding longevity and morbidity risk, Sept 2018
- ARC Sessional How medical advances and health interventions will shape future longevity, June 2018
- ARC Webinar Series 2017 Use of Big Health and Actuarial Data for understanding Longevity and Morbidity, June 2017
If you want more information about our research programmes please contact the IFoA Actuarial Research Centre:
Filter or search events
We continue to live in a world of global uncertainty. Survival depends on our ability to simultaneously navigate through the diverse root-causes, ranging from: the consequences of Climate Change; transitioning to Net Zero; increased inflationary pressures and supply chain issues; to self-imposed changes in regulatory requirements. CILA 2022 focuses on these challenges to ensure we continue to be informed and remain battle ready, as well as showcasing highlights of recent CMI outputs.
Opportunity to participate in a virtual Roundtable Discussion hosted by the IFoA in conjunction with the City of London Corporation’s Socio-economic Diversity Taskforce
In the spirit of fostering the IFoA’s vibrant, global community and enabling our members to participate, we have decided to hold our AGM virtually again this year. This allows for greater accessibility to this important annual event, and for greater accountability of our organisation.
The Business of the AGM
Join newly inaugurated IFoA President, Matt Saker, for his Presidential Address.
We’re delighted to welcome you back to our first in-person conference since early 2020, also being delivered virtually in our first-ever hybrid event. The theme of our inaugural two-day conference is ‘Focusing on tomorrow’s actuary’ and will explore the contribution actuarial science is making to some of tomorrow’s biggest issues.
This webinar will cover:
• Some background on the risks of misselling in an ESG context, including the DWS case
• Achieving positive impact is a strong antidote to the risks of greenwashing or ESG misselling, however this risks having a tension with fiduciary responsibilities
• This tension can be resolved with a concept called Universal Ownership
• Under Universal ownership, investors have an appetite to make a loss in order to achieve positive impact, and yet still have no compromise on their fiduciary responsibilities
This session will focus on the transformation roadmap of the healthcare sector in KSA and the role of actuarial capabilities in enhancing its evolution to the desired end stage as per the objectives of the Vision 2030. The discussion will focus how the system has evolved so far and shed light on the expected future changes. Through examining the transformation, we will highlight how the sector is and can use actuarial expertise to not only assist with this transformation but also use basic actuarial principles to identify the key risks and their respective mitigation strategies.